Main Management ETF Advisors, LLC Recursion Pharmaceuticals, Inc. Transaction History
Main Management ETF Advisors, LLC
- $2.06 Billion
- Q1 2025
A detailed history of Main Management ETF Advisors, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Main Management ETF Advisors, LLC holds 140,586 shares of RXRX stock, worth $639,666. This represents 0.04% of its overall portfolio holdings.
Number of Shares
140,586Holding current value
$639,666% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
366Shares Held
286MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$158 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$147 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$111 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$78.8 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$66.7 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $821M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...